PFIZER, INC
Lobbying client. Federal LDA filings.
Connected on the graph
Inbound (25)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Brent Alan Del Monte | lobbied_for | — | lda_lobbyist_client | |
| — | Gregory Nickerson | lobbied_for | — | lda_lobbyist_client | |
| — | Angela Boothe Wiles | lobbied_for | — | lda_lobbyist_client | |
| — | Zachary Austin Price | lobbied_for | — | lda_lobbyist_client | |
| — | Catherine Robinson | lobbied_for | — | lda_lobbyist_client | |
| — | Francisco Carrillo | lobbied_for | — | lda_lobbyist_client | |
| — | Raghav Aggarwal | lobbied_for | — | lda_lobbyist_client | |
| — | Matthew Stroia | lobbied_for | — | lda_lobbyist_client | |
| — | Stephen Claeys | lobbied_for | — | lda_lobbyist_client | |
| — | Robert Wood | lobbied_for | — | lda_lobbyist_client | |
| — | John Stone | lobbied_for | — | lda_lobbyist_client | |
| — | Daniel Farmer | lobbied_for | — | lda_lobbyist_client | |
| — | Hazen Clay Marshall | lobbied_for | — | lda_lobbyist_client | |
| — | Monica Popp | lobbied_for | — | lda_lobbyist_client | |
| — | Jennifer Swenson Walton | lobbied_for | — | lda_lobbyist_client | |
| — | Chris Kelly | lobbied_for | — | lda_lobbyist_client | |
| — | Emily Mueller | lobbied_for | — | lda_lobbyist_client | |
| — | Joel D. Bailey | lobbied_for | — | lda_lobbyist_client | |
| — | Marvin Benito Figueroa | lobbied_for | — | lda_lobbyist_client | |
| — | Remy Leigh Brim Mason | lobbied_for | — | lda_lobbyist_client | |
| 2026-01-01 | THE WASHINGTON TAX & PUBLIC POLICY GROUP | lobbies_for | $110,000 | lda_filing | |
| 2026-01-01 | PFIZER INC. | lobbies_for | $4,420,000 | lda_filing | |
| 2026-01-01 | BGR GOVERNMENT AFFAIRS | lobbies_for | — | lda_filing | |
| 2026-01-01 | MARSHALL & POPP, LLC | lobbies_for | $60,000 | lda_filing | |
| 2026-01-01 | ALTRIUS GROUP, LLC | lobbies_for | — | lda_filing |
Outbound (8)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 5509 — Safe Step Act | — | H.R. 5509 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 7837 — Most Favored Patient Act of 2026 | — | H.R. 7837 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 2903 — Safe Step Act | — | S. 2903 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 3510 — Biosimilar Inspection Modernization Act of 2025 | — | S. 3510 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1492 — To amend title XI of the Social Security Act to equalize the negotiation period between sm | — | H.R. 1492 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 7148 — Consolidated Appropriations Act, 2026 | — | H.R.7148 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1040 — Drug Competition Enhancement Act | — | S.1040 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1041 — Affordable Prescriptions for Patients Act | — | S.1041 | lobbying_bill_mention |
- Source id
106343- General description
- Biopharmaceutical company
- State
- NY
- Country
- US
- Principal place of business
- US
- Government-entity client
- false
- Effective date
- 2016-05-15
- Total spend (across 1 ingested filings)
- $0
Filings
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-01-12 | Q1 | 2026 | BGR GOVERNMENT AFFAIRS | — |